Anthropic's Claude accelerates Ebola outbreak response in DRC
Summary
In the Democratic Republic of the Congo, global health organizations, including CEPI and WHO AFRO, are implementing Claude AI to enhance their response to an outbreak of the rare Bundibugyo Ebola variant. Since May, health teams have faced nearly 8,000 confirmed cases, with a half of those infected succumbing to the disease. Claude is being used to streamline data collection from local health workers, accelerating the creation of situation reports, which has reduced the time to compile these reports from a day to less than an hour. Additionally, CEPI is investigating potential vaccine candidates for this strain, as there is currently no approved vaccine for Bundibugyo, while the existing Zaire strain vaccine is being evaluated for possible cross-protection.